NTRK fusion promotes tumor migration and invasion through epithelial–mesenchymal transition and closely interacts with ECM1 and NOVA1

Siqing Zeng, Ke Jiang, Jie Ge, Mimi Tang, Yuqi Wen, Xiaoting Ma, Heli Liu, Xingui Xiong · 2024

Read NTRK fusion promotes tumor migration and invasion through epithelial–mesenchymal transition and closely interacts with ECM1 and NOVA1 by Siqing Zeng, Ke Jiang, Jie Ge, Mimi Tang, Yuqi Wen, Xiaoting Ma, Heli Liu, Xingui Xiong (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11619257.txt.

Description

Siqing Zeng and co-authors published this cancer study in 2024 on NTRK fusion genes, rare drivers that form when pieces of two genes join. Clinicians prize them because targeted drugs can attack them, but their role in spreading cancer was unclear. The team found eight fusion-positive patients at their hospital and noticed their tumors seemed unusually mobile. They combined patient data, public database analysis, and cell experiments to probe the mechanism.

Two genes, ECM1 and NOVA1, rose and fell together with the fusion genes and tracked with a cell program that loosens tissue identity and enables invasion. Both genes are overproduced in several cancers and mark advanced disease. A targeted TRK drug blunted the fused cells' ability to invade in the lab. One surprise: suppressing ECM1 made the fused cells move more, not less. The authors say the relationship is complex and needs more work.

Catalog record

CREATORSiqing Zeng, Ke Jiang, Jie Ge, Mimi Tang, Yuqi Wen, Xiaoting Ma, Heli Liu, Xingui Xiong
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11619257

Browse the full library · About the Tower of Babel